INTERNATIONAL PATENT: SHANGHAI MABGEN BIOTECH LTD., 上海迈晋生物医药科技有限公司 FILES APPLICATION FOR "ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO EGFR AND CMET, DRUG CONJUGATE THEREOF AND MEDICAL USE THEREOF"

GENEVA, Dec. 8 -- SHANGHAI MABGEN BIOTECH LTD. (Third Floor, No.5 Building, No.18 Jindian Road, Free Trade Pilot ZonePudong New Area, Shanghai 201206), 上海迈晋生物医药科技有限公司 (中国上海市浦东新区自由贸易试验区金滇路18号5幢第3层) filed a patent application (PCT/CN2025/097404) for "ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO EGFR AND CMET, DRUG CONJUGATE THEREOF, AND MEDICAL USE THEREOF" on May 27, 2025. With publication no. WO/2025/247206, the details related to the patent application was published on Dec 04, 2025...